Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Plos One|March 27, 2010
Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young miceSimon Gengler, Alison Hamilton, Christian HölscherJournal of Alzheimer'S Disease : JAD|October 5, 2018
The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse ModelTheodora Panagaki, Simon Gengler, Christian HölscherBehavioural Brain Research|July 26, 2005
Inactivation of the rat dorsal striatum impairs performance in spatial tasks and alters hippocampal theta in the freely moving ratSimon Gengler, Hanspeter A Mallot, Christian HölscherExperimental Brain Research|December 16, 2006
Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic backgroundSimon Gengler, Victor A Gault, Patrick Harriott, et al.Neuropharmacology|February 23, 2017
A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's diseaseJaishree Jalewa, Mohit Kumar Sharma, Simon Gengler, et al.Neurobiology of Aging|April 3, 2010
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 miceSimon Gengler, Paula L McClean, Ruth McCurtin, et al.European Journal of Pharmacology|February 27, 2007
Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learningChristian Holscher, Simon Gengler, Victor A Gault, et al.American Journal of Alzheimer'S Disease and Other Dementias|September 22, 2020
The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's DiseaseMark Maskery, Elizabeth Mary Goulding, Simon Gengler, et al.Neuropharmacology|November 15, 2018
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathologyMartina Holubová, Lucie Hrubá, Andrea Popelová, et al.EMBO Reports|August 15, 2006
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyRebecca Radde, Tristan Bolmont, Stephan A Kaeser, et al.Pageof 1